The Trucheck test is an advanced non-invasive blood test for the early detection of cancer.
The test detects circulating tumour cells (CTCs) released by malignant tumours and can identify several types of solid tumours with high accuracy.
The Trucheck test allows cancer to be detected at an early stage, improving the chances of successful treatment.
It is mainly recommended for people aged between 40 and 70, but younger individuals at increased risk of cancer can also have it.
...asymptomatic individuals with a family history of cancer.
...individuals who want to include this test in their annual health check-up
...asymptomatic individuals at high risk of cancer.
No queues
Results in 10-14 days
Only a blood test is needed
Experienced specialists
Around 4.4 million new cancers are diagnosed in Europe every year, as are around 2 million cancer-related deaths.
Unfortunately, cancer is often only detected at an advanced stage, requiring more intensive and expensive treatments that have a higher risk of side effects.
Early detection of cancer, or detection at local stages, can be the key to successful treatment.
Trucheck™ is the result of several years of collaborative international research and innovation and has been developed, tested and validated in more than 40,000 individuals.
Unlike screening tests that target one cancer at a time, Trucheck™ can detect multiple cancers that may not be detected by existing technologies with a simple blood draw. Detection at earlier stages is associated with higher treatment success and improved survival.
Trucheck™ intelli screens CTCs (circulating tumour cells) according to the molecular footprint of the tumour mass from which the CTCs originated. In other words, Trucheck™ intelli reveals diagnostically relevant information about the tissue or organ of origin of the tumour with high precision. This guides further investigations and reduces diagnostic trial and error.
Trucheck™ is an advanced comprehensive cancer detection system that offers an unparalleled combination of sensitivity and specificity for the early detection of cancer in asymptomatic individuals.
The following options are available:
Are there age limits for Trucheck™ analysis?
If yes, are there exceptions?
Trucheck™ is recommended for individuals aged between 40 and 70 years, as ageing is an important risk factor for cancer.
However, it may also be offered to individuals aged 35 to 40 years if any of the following risk factors apply:
1. Family history of cancer and/or known carrier status
2. Presence of risk inherited germ cell mutations
3. Obesity
4. Type 2 diabetes
5. Past infections (HPV, Hepatitis B or C viruses)
6. Documented/significant exposure to certain chemicals or carcinogens.
What are the benefits of Trucheck™ analysis?
Trucheck™ only requires a simple blood test.
Cancers that are not detected by current standard methods can be detected.
Early detection of cancer is linked to better treatment success.
What are the risks of Trucheck™ analysis?
Knowing that you are at risk or have cancer, even if it is at an early stage, can have a significant psychological impact on patients.
Patients should be aware that they may still need to have regular screening tests according to established guidelines, as Trucheck™ is not intended to replace standard cancer screening methods.
“I have suffered from chronic joint pain, especially in my knees, for several years. Traditional treatments such as physical therapy, painkillers and even corticosteroid injections have only provided temporary relief. Desperate for a more permanent solution, I started researching alternative treatments and came across mesenchymal stem/stromal cell (MSC) therapy. After consulting my doctor and doing extensive research, I decided to give it a try.
The treatment process was simple and professionally managed. The first consultation included a thorough assessment of my condition and detailed information on how MSC therapy works. The procedure itself was minimally invasive and surprisingly quick.
What surprised me most was the gradual but noticeable improvement in my condition. Within a few weeks I felt significant pain relief and increased mobility. Tasks that had become difficult or impossible, such as walking up stairs, lifting objects and even walking for long periods of time, became much easier. The stiffness and constant pain that had plagued me for years were greatly reduced. Three months after treatment, I can say with certainty that the improvement has been remarkable. The quality of my life has improved significantly.
I highly recommend MSC therapy to anyone who suffers from chronic joint pain. It has been a game changer for me, providing long term relief where other treatments have failed. The professionalism and care of the medical team (Crystal?) combined with the innovation of the treatment made for an exceptional experience. If you are considering this option, I would recommend that you consult with a qualified healthcare professional to determine whether MSC therapy could be the solution you have been looking for. “
“My name is Milena and I am happy to share my experience of stem cell therapy for Heberden’s and Bouchard’s osteoarthritis of the toes. For years I have been struggling with unbearable pain and swelling in most of my fingers, but especially in three of them, which has affected my daily life.
After extensive research and consultations, I was advised by rheumatologists that medicine has no cure for small joint diseases and that I can only relieve them with painkillers. So I decided to try stem cell therapy. In the procedure, stem cells were injected into each joint of the fingers of both hands. The procedure went smoothly and professionally, but also with not too much pain.
The results were great. I noticed a significant reduction in swelling and pain in a short time. Gradually, the mobility of my fingers improved to some extent, but most importantly, I no longer woke up at night in pain, I no longer had to take painkillers and I was able to do everyday tasks again, including gardening.
Stem cell therapy has made my life easier and, above all, it has eliminated the need to take painkillers, which in the long run also have side effects. I am immensely grateful for the advances in medical science that have made this possible and for the skilled professionals who have guided the treatment. If you suffer from osteoarthritis, I recommend that you opt for stem cell therapy.”